Cadila board approves transfer of animal healthcare arm to Zydus Health

Cadila Pharmaceuticals

Drug firm Cadila Healthcare on Wednesday said its board has approved the transfer of its animal healthcare business on a going concern basis to its wholly-owned arm Zydus Animal Health and Investments Ltd (ZAHL) as part of its internal restructuring exercise.

The transfer of animal healthcare business is through execution of a definitive agreement, Cadila Healthcare said in a filing to BSE.

The animal healthcare business (AHB) consists of development, manufacturing, marketing and selling of animal healthcare products in India and other countries, it added.

"No cash consideration will be paid by ZAHL for transfer of AHB. ZAHL will issue and allot 227,33,50,000, 8 per cent non-convertible non-cumulative redeemable preference shares of Rs 10 each at face value, aggregating to Rs 2,273.35 crore, in exchange for transfer of AHB," Cadila Healthcare said.

ZAHL is engaged in the business of pharmaceuticals and investments, it added.

Cadila Healthcare Ltd and ZAHL are the parties to the definitive agreement, the filing said.

Cadila Healthcare shares closed at Rs 258.15 on BSE, up 0.84 per cent from the previous close.



Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel